E-LIB Suche - Ergebnisse für: Bermejo, Begoña

1

Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PI..:

Llombart-Cussac, Antonio ; Pérez-Garcia, José Manuel ; Ruiz Borrego, Manuel...
eClinicalMedicine. 71 (2024) - p. 102520 , 2024

Link: https://doi.org/10.1016/..

2

Biomarkers in breast cancer 2024: an updated consensus stat..:

Colomer, Ramon ; González-Farré, Blanca ; Ballesteros, Ana Isabel...
Clinical and Translational Oncology. , 2024

Link: https://doi.org/10.1007/..

3

Cross-sectional and longitudinal associations of adherence ..:

Lope, Virginia ; Guerrero-Zotano, Ángel ; Fernández de Larrea-Baz, Nerea...
The Journal of nutrition, health and aging. 28 (2024) 8 - p. 100312 , 2024

Link: https://doi.org/10.1016/..

4

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the cli..:

Santana-Hernández, Sara ; Suarez-Olmos, Jesús ; Servitja, Sonia...
Journal of Experimental & Clinical Cancer Research. 43 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

3-year invasive disease-free survival with chemotherapy de-..:

Pérez-García, José Manuel ; Cortés, Javier ; Ruiz-Borrego, Manuel...
The Lancet. 403 (2024) 10437 - p. 1649-1659 , 2024

Link: https://doi.org/10.1016/..

6

Correlation between trophoblast cell-surface antigen-2 (Tro..:

Gion, María ; García-Mosquera, Juan José ; Pérez-García, José Manuel...
Breast Cancer Research and Treatment. 205 (2024) 3 - p. 589-598 , 2024

Link: https://doi.org/10.1007/..

7

Olaparib plus trastuzumab in HER2-positive advanced breast ..:

Alés-Martínez, José Enrique ; Balmaña, Judith ; Sánchez-Rovira, Pedro...
The Breast. 77 (2024) - p. 103780 , 2024

Link: https://doi.org/10.1016/..

8

Spatial predictors of immunotherapy response in triple-nega..:

Wang, Xiao Qian ; Danenberg, Esther ; Huang, Chiun-Sheng...
Nature. 621 (2023) 7980 - p. 868-876 , 2023

Link: https://doi.org/10.1038/..

9

Clinical Impact of New Treatment Strategies for HER2-Positi..:

Tapia, Marta ; Hernando, Cristina ; Martínez, María Teresa...
Cancers. 15 (2023) 18 - p. 4522 , 2023

Link: https://doi.org/10.3390/..

10

CCNE1andPLK1Mediate Resistance to Palbociclib in HR+/HER2− ..:

Guerrero-Zotano, Ángel ; Belli, Stefania ; Zielinski, Christoph...
Clinical Cancer Research. 29 (2023) 8 - p. 1557-1568 , 2023

Link: https://doi.org/10.1158/..

11

Long-term outcomes of high-risk HR-positive and HER2-negati..:

Martín, Miguel ; Carrasco, Eva ; Rodríguez-Lescure, Álvaro...
Breast Cancer Research and Treatment. 201 (2023) 2 - p. 151-159 , 2023

Link: https://doi.org/10.1007/..

12

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Trip..:

Torres-Ruiz, Sandra ; Tormo, Eduardo ; Garrido-Cano, Iris...
International Journal of Molecular Sciences. 24 (2023) 4 - p. 3601 , 2023

Link: https://doi.org/10.3390/..

13

miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab R..:

Cabello, Paula ; Torres-Ruiz, Sandra ; Adam-Artigues, Anna...
Cancers. 15 (2023) 7 - p. 2138 , 2023

Link: https://doi.org/10.3390/..

14

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Sil..:

Garrido-Cano, Iris ; Adam-Artigues, Anna ; Lameirinhas, Ana...
ACS Applied Materials & Interfaces. 15 (2023) 32 - p. 38323-38334 , 2023

Link: https://doi.org/10.1021/..

15

Baseline Mutations and ctDNA Dynamics as Prognostic and Pre..:

Pascual, Javier ; Gil-Gil, Miguel ; Proszek, Paula...
Clinical Cancer Research. 29 (2023) 20 - p. 4166-4177 , 2023

Link: https://doi.org/10.1158/..